Madrigal Pharmaceuticals
MDGL
MDGL
135 hedge funds and large institutions have $1.19B invested in Madrigal Pharmaceuticals in 2019 Q1 according to their latest regulatory filings, with 23 funds opening new positions, 50 increasing their positions, 31 reducing their positions, and 23 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
135
Holders Change
-1
Holders Change %
-0.74%
% of All Funds
2.93%
Holding in Top 10
3
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+200%
% of All Funds
0.07%
New
23
Increased
50
Reduced
31
Closed
23
Calls
$79.4M
Puts
$34.3M
Net Calls
+$45.1M
Net Calls Change
-$34M
Top Buyers
Top Sellers
| 1 |
JPMorgan Chase & Co
New York
|
$211K |
| 2 |
Morgan Stanley
New York
|
$1.68M |
| 3 |
Citigroup
New York
|
$129K |
| 4 |
AG
Artal Group
Luxembourg
|
$4.38M |
| 5 |
State Street
Boston,
Massachusetts
|
$70.9M |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
151
Bessemer Group
Woodbridge,
New Jersey
| – | -$116K | -1,033 | Closed |
|
|
GTC
152
Ghost Tree Capital
New York
| – | -$101K | -900 | Closed |
|
|
MAM
153
Meeder Asset Management
Dublin,
Ohio
| – | -$63K | -557 | Closed |
|
154
SEI Investments
Oaks,
Pennsylvania
| – | -$100K | -465 | Closed |
|
|
ER
155
Enlightenment Research
Miami,
Florida
| – | -$23K | -200 | Closed |
|
|
GT
156
Glenmede Trust
Philadelphia,
Pennsylvania
| – | -$7 | -68 | Closed |
|